Cellular proliferation, specification and differentiation in developing tissues are tightly coordinated by groups of transcription factors in response to extrinsic and intrinsic signals. Furthermore, renewable pools of stem cells in adult tissues are subject to similar regulation. Basic helix-loop-helix (bHLH) proteins are a group of transcription factors that exert such a determinative influence on a variety of developmental pathways from C. elegans to humans, and we wished to exclusively identify novel members from within the whole human bHLH family. We have, therefore, developed an 'empirical custom fingerprint', to define the class II bHLH domain and exclusively identify these proteins in silico. We have identified nine previously uncharacterised human class II proteins, four of which were novel, by interrogating conceptual translations of the GenBank HTGS database. RT-PCR and mammalian 2-hybrid analysis of a subset of the factors demonstrated that they were indeed expressed, and were able to interact with an appropriate binding partner in vitro. Thus, we are now approaching an almost complete listing of human class II bHLH factors. q 2003 Elsevier Science Ireland Ltd. All rights reserved.
Results and discussion
It is likely that class II factors regulate many hitherto unrecognised pathways, as the expression of their interaction partners, the class I and V proteins, is widespread (Murre et al., 1994) . It is, therefore, of particular interest to identify other members of the class II family. Library screening, e.g. using the yeast 2-hybrid method, is traditionally used to identify novel interaction partners, but as the expression window may be narrow such analysis is necessarily limited by the availability of appropriate libraries which are generally murine. We sought to exploit an alternative genomic database searching approach to the identification of novel human class II genes. Thus, we developed a computer program to screen the draft human genome sequence using a novel search pattern based on conserved residues in the basic helix-loop-helix (bHLH) domain of a subset of known human class II factors. Conceptual translations were generated from the entire crude and finished genome data available from the high-throughput genome screening (HTGS) database at GenBank, and screened with the novel search pattern. The bHLH motifs of previously characterised and novel class II factors were aligned using Clustal W (Thompson et al., 1994) to generate a neighbour-joining (NJ) tree and show class II factor relationships. Furthermore, using RT-PCR and mammalian 2-hybrid analysis, we have determined that some of the genes were expressed in human tissues and interacted with members of the class I family in vitro.
Identification of novel human class II bHLH factors
A total of 42,120 sequences from the HTGS database at GenBank were translated in all six reading frames, yielding 6.7 £ 10 7 hypothetical peptide sequences greater than or equal to an arbitrary 40 residues in length between stop codons. Only 79 of those peptide sequences identified by our search pattern (Fig. 1a) encoded class II bHLH domains, several of which represented the same protein due to redundancy in the database. Subsequent BLAST analysis revealed all the known members of the class II bHLH subfamily and many hitherto unidentified or undefined members, most of which were clearly orthologues of known mouse members based on extremely high sequence conservation, particularly within the helix-loop-helix domain where identity was often 100% (Table 1) . No sequences were returned that did not represent known class II bHLH proteins or valid candidates, hence we believe that our search pattern defines the human class II bHLH domain. Complete DNA-coding and protein sequences of ten human class II bHLH factors not yet represented in the published databases were deduced as orthologues of mouse genes, of which five have been recently partially characterised by others. Moreover, we identified open reading frames encoding the bHLH domain of four novel factors for which no mouse orthologue is evident.
The helix-loop-helix super-family can be divided into discrete categories according to phylogenetic relationships (Atchley and Fitch, 1997) , or according to dimerisation, DNA binding, and expression characteristics (Murre et al., 1994) . We chose to adopt the latter subdivision into seven groups as this approach readily facilitated the isolation of distinct HLH families by function. Thus, peptide sequences of existing and novel human class II bHLH domains were The consensus derived from human class II factor bHLH alignments was split into two search patterns, one for each helix. The format is based on the PROSITE syntax (Hofmann et al., 1999) ; 'x': any amino acid; '[]': only residues inside square parenthesis are allowed in that position; '{}': residues inside curly brackets are forbidden in that position; '(n)': a pattern element is repeated at least n times; '-': separates each pattern element. The '[ u ]' format is not standard PROSITE syntax and means that either the pattern on the left or the right of the 'u' is permitted. (b) Multialign representation of all known human class II bHLH-domains. Homology is shown as: ,50%, black type; 50-90%, blue type; .90%, red type. aligned, using Multialign (Corpet, 1988) (Fig. 1b) , and then using Clustal W (Thompson et al., 1994) to generate a neighbour-joining plot (Fig. 2) , thus presenting our findings in a way that highlights class II subfamily relationships. The plot in Fig. 2 also facilitated positioning of the four novel paralogous class II bHLH proteins, which have been named within the guidelines set by the International Committee on Standardised Genetic Nomenclature.
Characterisation of predicted peptides
Due to the lack of availability of human embryonic material for in situ analysis, we chose to study gene expression usingthe Clontech human foetal MTC panel of cDNAs prepared from pooled male and female foetuses of Caucasian origin. This facilitated expression profiling within a limited developmental window (16-36 weeks). Expression of six genes was investigated by PCR as shown in Fig. 3 , and interaction with a potential in vivo binding partner, the class I bHLH factor HEB, was tested for a subset of these factors (Fig. 4) .
Ptf1a (PTF1-p48) expression is essential for exocrine pancreas development and is the earliest exocrine-specific marker observed during embryogenesis in mice (Krapp et al., 1996) . It transactivates digestive enzyme genes in acinar cells as a complex with either E12 or a truncated form of HEB (Cockell et al., 1995; Roux et al., 1989) . We report the discovery of the human orthologue of this factor, PTF1a. According to our NJ tree ( Fig. 2 ) this factor represents a distinct and poorly related member of the Achete-Scute-like (ASCL) sub-group, of which ASCL4 and ASCL5 are also novel members which we describe for the first time. The majority of ASCL group members are involved in neurogenesis (Guillemot and Joyner, 1993; Lo et al., 1991) , and indeed we have shown ASCL4 and ASCL5 to be expressed in foetal brain (Fig. 3) , although ASCL5 exhibited a wide expression profile, with expression observed in lung, kidney, spleen and skeletal muscle. Moreover, ASCL4 interacted strongly with the class I protein HEB in a mammalian 2-hybrid assay (Fig. 4) .
The human orthologue of murine bHLH protein Mist1 was also identified and found to be most closely related to the NEUROD/NEUROG and Beta3 subfamilies (Fig. 2) . Mist1 is a class II factor, expressed specifically in pancreatic acinar cells, that possesses an N-terminal repressor region instead of an activation domain, and acts as a functional repressor of MyoD1 (Lemercier et al., 1998) . Whereas Ptf1a is required for acinar cell determination, Mist1 has been shown to be necessary for complete acinar cell maturation and maintenance of normal function (Pin et al., 2001 ). MIST1 may therefore have an important role to play in human pancreatic disease, because absence of expression in mice leads to pancreatic injury (Pin et al., 2001) . We found that MIST1 expression was widespread in human foetal tissues, with expression in brain, liver, spleen and skeletal muscle (Fig.  3) . Another subfamily member, ATOH7, has been characterised previously (Brown et al., 2002) , although we have determined the complete peptide and DNA-coding sequence for entry into the GenBank Third Party Annotation database.
Scx (scleraxis) is a class II bHLH factor essential for normal mesodermal development, as transgenic mice that do not express Scx fail to form mesoderm and do not undergo gastrulation (Brown et al., 1999) . Later expression of this protein was recently found to be specific to developing tendons and ligaments (which mediate attachment of muscle to bone and bone to bone, respectively) (Schweitzer et al., 2001) . Its expression in tendons spans from the early progenitor stage (in the superficial proximomedial mesenchyme of early limb buds) to the formation of mature tissue. We report the identification of the complete DNA-coding and peptide sequence of human SCX which maps to chromosome 8.
Murine Tcf23 (OUT) was discovered relatively recently and was shown to be expressed in adult reproductive tissues, e.g. ovary, uterus and testis, with a C-terminal mediated inhibitory action (Narumi et al., 2000) . The mapping of the human orthologue TCF23 has since been described, although the sequence information was not published (Tachibana et al., 2001) . We investigated the expression pattern of TCF23 and found it to be expressed in liver, kidney and spleen only (Fig.  3) . A relatively weak interaction with the class I protein HEB was detected in our mammalian 2-hybrid assay (Fig. 4) . We also report the discovery of a paralogue of TCF23. The novel gene maps to chromosome location 8q12 and we name it TCF24 (OUT2).
The human orthologues of murine proteins Olig1 and Olig2 have been previously characterised (Lu et al., 2001) . However, the DNA-coding and amino acid sequences of OLIG1, which is expressed from a single exon, have not been published to date. Furthermore, we now report the identification of the human orthologue of Olig3. RT-PCR analysis demonstrated that OLIG3 was not expressed in any of the human foetal tissues represented in the cDNA panel (Fig. 3) . However, mammalian 2-hybrid analysis suggested that OLIG3 is a relatively weak interactor with the class I protein HEB, compared with the strong positive control used in these experiments (Fig. 4) . Indeed, a Fig. 3 . PCR expression data using genomic DNA free first strand cDNA preparations from pooled tissues of male and female Caucasian foetuses, 16-36 weeks. The expression pattern of six novel class II bHLH factors; ASCL4, ASCLl5, OLIG3, MIST1, MESP2 and TCF23 was determined. A GAPDH control is included to verify cDNA quality. Each PCR includes amplification from a human genomic DNA (gDNA) positive control (or from a Clontech control cDNA for the GAPDH reactions), and a notemplate control (NTC). Fig. 4 . Interaction characteristics of novel class II bHLH factors. The histogram shows relative binding affinity of each factor with the class I factor HEB. Error bars represent standard deviations of the mean for duplicate assays, and statistical significance using the student t-test (*P , 0:05, **P , 0:01). broad spectrum of interaction affinities has been reported for class II genes with E-proteins (Langlands et al., 1997 ). Olig1 and Olig2 were shown to be expressed by oligodendrocytes in mice, and the human orthologues have since been shown to demonstrate an identical pattern of expression. Moreover, they are highly expressed only in oligodendroglial tumours (Lu et al., 2001 ).
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The complete amino-acid sequences of BHLHB4 and BHLHB5 have also been deduced using our analysis. The existence of human orthologues of these genes was recently noted by Bramblett et al. (2002) , who suggested that BHLHB4, BHLHB5, OLIG1, OLIG2, OLIG3 and MIST1 should be sub-classified into the Beta3 subfamily. Murine BhlhB4 is expressed in pancreatic duct epithelium for a limited period during development, and is also expressed in brain throughout embryogenesis, where it acts as a transcriptional repressor and promotes differentiation (Bramblett et al., 2002) . BhlhB5 also acts as a transcriptional repressor, interacting with E47 to prevent NeuroD1/E47 heterodimerisation (Peyton et al., 1996) . It is known to be expressed in brain, lung and kidney.
Finally, we have identified the human orthologue of MesP2. The murine factor is involved in the notch signalling pathway during development of the presomitic mesoderm (Koizumi et al., 2001) . A putative relative of the MESP genes appears to be novel protein, basic helix-loop-helix factor 42 (bHLHF42), according to the dendrogram (Fig. 2 ) although we were unable to characterise this gene further.
Conclusions
There is much current interest in the identification of novel HLH genes, illustrated by three relatively recent reports describing computational approaches to the discovery of HLH genes from the completely sequenced C. elegans and D. melanogaster genomes (Ledent and Vervoort, 2001; Moore et al., 2000; Peyrefitte et al., 2001) . Our computational approach has allowed us to identify novel human bHLH factors which have been previously overlooked, probably due to limited expression patterns in embryonic tissue which is difficult to obtain. Although the human genome database is still highly redundant, it was possible to perform a 'virtual library screen' using a highly accurate class II bHLH specific pattern searching method. Only one known human factor was missed by our search, DERMO1 (Lee et al., 2000) , and its absence from the HTGS database was confirmed by BLAST analysis using the reported human cDNA sequence. We assume based on the draft human genome nearing completion, that we are approaching a complete set of human class II basic helix-loop-helix factors.
Class II bHLH transcription factors provide fundamental regulation of developmental pathways and also maintenance of structure, thus we hope this work will prompt re-evaluation of their roles in a broad range of tissues. Moreover, a growing body of evidence suggests a role for bHLH genes in human disease. Class I, II and V HLH genes have been implicated in malignant transformation (Ito et al., 2001; Langlands et al., 2000; Maestro et al., 1999; Persson et al., 2000; Porcher et al., 1996; Wang et al., 2000) , and potential roles have been suggested in diabetes and obesity (Bramblett et al., 2002) and pancreatic disease (Pin et al., 2001) . Certainly the functional relationship between PTF1a, BHLHB4 and BHLHB5 is proving to be a growing area of interest in terms of pancreatic morphogenesis and maintenance.
Our strategy for identifying novel class II bHLH factors may be applied to identifying class II factors from other genomes as they become available. Furthermore, we believe that the methods we have applied could be tailored to detect new members of other classes of HLH factors, or perhaps of other subclasses of proteins characterised by different domains. 
Experimental procedures

Materials
Unless otherwise indicated, all reagents specified were obtained from Sigma Ltd (Poole, UK).
Algorithm development and implementation
A Perl program was written and executed under ActivePerl v5.6.0616 (ActiveState: http://www.activestate.com) on a Windows 98 (Microsoft) platform. The program was designed to read either proteomic or genomic sequences in Fasta format flat files. SWISS-PROT, TrEMBL and TrEMBL-new protein sequence files (Bairoch and Apweiler, 2000) were downloaded from the Expasy ftp server (ftp:// ftp.expasy.org/databases/sp_tr_nrdb/fasta/), high throughput genomic sequence (HTGS) files (phases 0 to 3) from the GenBank repository (ftp://ncbi.nlm.nih.gov/genbank/ genomes/H_sapiens/) and Ensembl 3.26.1 confirmed peptide data from their download site (ftp://ftp.Ensembl.org/current/ data/fasta/pep/). The program iterated through each file, translating each genomic DNA sequence in all six reading frames, checking each putative peptide sequence greater than an arbitary 40 residues in length against the regular expression shown in Fig. 1a .
The pattern was developed and tested using the annotated SWISS-PROT, TrEMBL and TrEMBL-new databases. The final working pattern was made up of four residues from helix 1, and seven from helix 2, allowing a loop of variable length, and one conserved residue in either helix 1 or 2 (but not both) to vary from the pattern. A restriction allowing only one glycine residue in either positions 2 or 3 of helix 2 prevented identification of USF and its related factors which are not class II members but otherwise match the pattern. Peptide sequences of matching helices were returned and, when screening genomic databases, open reading frame DNA and corresponding peptide sequences. This permitted identification of the proteins of nearest homology, using a BLAST search (Altschul et al., 1997) of the non-redundant (nr) protein database at the NCBI (http://www.ncbi.nlm. nih.gov). Where murine sequence was available, it was possible to identify the full coding sequences of human orthologues by homology.
Plasmids
bHLH domains, with an additional 30 residues on either side, were PCR amplified using Jumpstart RED accu-Taq according to the manufacturers instructions, using 500 ng human genomic DNA, oligonucleotide primers (MWGBiotech AG, Ebersberg, Germany) as shown in Table 2 , and 30 cycles of 948C for 30 s, 558C for 1 min and 688C for 1 min. PCR products were cloned into pSG424 (Sadowski and Ptashne, 1989) . All other plasmids were as previously described (Iwama et al., 1999; Langlands et al., 1997) .
Mammalian 2-hybrid assays
One microgram of pNLVP16/HEB or pNLVP16 was cotransfected into HeLa cells using FuGene 6 reagent (Roche, Lewes, UK) with 1 mg of the appropriate pSG424 construct and 1 mg of the pHDluc reporter (a kind gift from Dr A.J. Bloor, Department of Haematology, Addenbrooke's Hospital, Cambridge, UK). Luciferase assays were performed using a luciferase reporter assay kit (Promega, Southampton, UK), and transfections normalised with pCMVbgal expression (Clontech, Basingstoke, UK). Results were compared with the strong interaction between HEB and ID1, a class V factor. The value for the ID1 interaction was set at 100 such that interactions of novel proteins were represented as a percentage of the ID1 interaction with HEB.
PCR
The human foetal MTC panel (Clontech, Palo Alto, CA, USA) provided the template cDNA for PCR. The panel represents pooled male and female Caucasian foetuses, age 16-36 weeks, and is supplied as genomic DNA free first strand cDNA preparations from a variety of tissues. Amplification was performed under standard conditions using Jump-Start RED Taq, the primer pairs shown in Table 2 (except for GAPDH for which primers supplied with the Clontech cDNA panel were used), and 35 cycles of the following: 948C for 30 s, 558C for 30 s and 728C for 30 s. Products were visualised on a 2% agarose gel by ethidium bromide staining.
